Pillstats
Rx only · Suspension · Oral

Sodium Polystyrene Sulfonate

Brands: Kionex · Sodium Polystyrene Sulfonate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)56512
US makers4 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.114$0.228$0.342$0.456Apr 2025Mar 2026Jul 2026
$0.374
Latest avg · Jul 22, 2026
-6%
Since Apr 23, 2025
4
Active US suppliers
71%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.9K3.8K5.7K7.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.4K
Rx · 2026 Q1
1.8M
Units dispensed
-18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
CMP Pharma, Inc.unknown3SUPPLYING
Burel Pharmaceuticals, LLCunknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.